首页> 外文期刊>Progress in Neuro-Psychopharmacology & Biological Psychiatry: An International Research, Review and News Journal >Would I take antipsychotics, if I had psychotic symptoms? Examining determinants of the decision to take antipsychotics
【24h】

Would I take antipsychotics, if I had psychotic symptoms? Examining determinants of the decision to take antipsychotics

机译:如果我有精神病症状,我会服用抗精神病药吗? 检查决定采取抗精神病学的决定

获取原文
获取原文并翻译 | 示例
           

摘要

Poor adherence to treatment in schizophrenia is mainly associated to patients-related factors. However, social negative representations of schizophrenia and its treatment may also contribute to patients' decision to take or not to take antipsychotics. A web-based study on 1,807 participants was conducted during which participants imagined that they had a particular chronic illness based on clinical vignettes (mental illnesses: schizophrenia, depression; somatic illnesses: multiple sclerosis, rheumatoid arthritis). Participants rated their subjective distress and perceived social stigma associated with each illness. They also rated the perceived treatability of the illness, their belief in the effectiveness of treatment, and their treatment preference regarding medication. Results show that schizophrenia was considered more distressful, less treatable and associated with higher social stigma than somatic illnesses. Medication was less preferred for treating schizophrenia compared to somatic illnesses. Perceived treatability of illness and belief in the effectiveness of pharmacological treatment were the factors driving preference for medication in schizophrenia and depression, respectively; these factors had weaker influence on preference for medication in somatic illnesses. Our study points out more severe negative representations of mental illnesses in general, and their treatment, particularly schizophrenia. These attitudes are not confined to patients, and may influence patients' decisions to take psychotropic drugs.
机译:精神分裂症治疗的粘附性不良主要与患者有关的因素有关。然而,精神分裂症的社会负面陈述​​及其治疗也可能有助于患者的决定服用或不服用抗精神病药。对1,807名参与者进行了一项基于网络的研究,在此期间,参与者想象他们基于临床小叶(精神疾病:精神分裂症,抑郁症;抑郁症;躯体疾病,类风湿性关节炎)进行了特定的慢性疾病。参与者评定了他们的主观痛苦和感知与每种疾病相关的社会耻辱。他们还评估了疾病的感知治疗能力,它们对治疗有效性的信念及其对药物治疗的治疗偏好。结果表明,精神分裂症被认为更令人痛苦,可治疗较少,与较高的社会耻辱相关,而不是躯体疾病。与躯体疾病相比,治疗精神分裂症的药物不太优选。感知疾病的治疗和对药理学治疗有效性的信念分别是在精神分裂症和抑郁症中促进药物治疗的因素。这些因素对躯体疾病中的药物偏好影响较弱。我们的研究指出了一般的精神疾病的更严重的阴性表示,以及他们的治疗,特别是精神分裂症。这些态度并不局限于患者,可能影响患者的患者采取精神药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号